Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168,154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a Risk Prediction Model of Subsequent Bloodstream Infection After Carbapenem-Resistant Enterobacteriaceae Isolated from Perianal Swabs in Hematological Patients.
Liu J, Zhang H, Feng D, Wang J, Wang M, Shen B, Cao Y, Zhang X, Lin Q, Zhang F, Zheng Y, Xiao Z, Zhu X, Zhang L, Wang J, Pang A, Han M, Feng S, Jiang E. Liu J, et al. Among authors: zhang l, zhang f, zhang h, zhang x. Infect Drug Resist. 2023 Mar 6;16:1297-1312. doi: 10.2147/IDR.S400939. eCollection 2023. Infect Drug Resist. 2023. PMID: 36910516 Free PMC article.
Haematopoietic stem cell transplantation for hepatitis-associated aplastic anaemia and non-hepatitis-associated aplastic anaemia: A propensity score-matched analysis.
Li J, Wang Y, Zhang Y, Zhang X, Pang A, Yang D, Chen X, Zhang R, Wei J, Ma Q, Zhai W, He Y, Zheng Y, Jiang E, Han M, Feng S. Li J, et al. Among authors: zhang r, zhang x, zhang y. Br J Haematol. 2023 Jun;201(6):1179-1191. doi: 10.1111/bjh.18779. Epub 2023 Mar 30. Br J Haematol. 2023. PMID: 36994699 Review.
Treatment With the Combination of Rituximab and Intravenous γ Globulin Is Effective in Promoting Engraftment in Donor-Specific Antibody Positive Patients Receiving Myeloablative Conditioning Haploidentical Stem Cell Transplantation.
Shen Y, Zhang L, Zhang X, Zhang T, Jiang E, Feng S, He Y, Zhang R. Shen Y, et al. Among authors: zhang l, zhang r, zhang t, zhang x. Transplant Cell Ther. 2023 Aug;29(8):514.e1-514.e6. doi: 10.1016/j.jtct.2023.05.005. Epub 2023 May 11. Transplant Cell Ther. 2023. PMID: 37178922 Free article.
Chidamide maintenance therapy in high-risk T-ALL/T-LBL after allo-HSCT: a prospective, single-center, single-arm study.
Guo W, Cao Y, Liu J, Zheng X, Wang M, Zheng Y, Zhang X, Zhai W, Chen X, Zhang R, Ma Q, Yang D, Wei J, He Y, Pang A, Feng S, Han M, Jiang E. Guo W, et al. Among authors: zhang r, zhang x. Bone Marrow Transplant. 2023 Oct;58(10):1163-1166. doi: 10.1038/s41409-023-02045-w. Epub 2023 Jul 20. Bone Marrow Transplant. 2023. PMID: 37474728 No abstract available.
ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming.
Zhang ZJ, Wu QF, Ren AQ, Chen Q, Shi JZ, Li JP, Liu XY, Zhang ZJ, Tang YZ, Zhao Y, Yao NN, Zhang XY, Liu CP, Dong G, Zhao JX, Xu MJ, Yue YQ, Hu J, Sun F, Liu Y, Ao QL, Zhou FL, Wu H, Zhang TC, Zhu HC. Zhang ZJ, et al. Acta Pharmacol Sin. 2023 Nov;44(11):2282-2295. doi: 10.1038/s41401-023-01108-4. Epub 2023 Jun 6. Acta Pharmacol Sin. 2023. PMID: 37280363
168,154 results
You have reached the last available page of results. Please see the User Guide for more information.